Intro

This chapter examines the rapid rise in the use of weight-loss medications like Ozempic and Wegovi through telehealth services. It addresses the potential risks associated with unregulated prescriptions, particularly for individuals with eating disorders, and challenges the responsibilities of telehealth providers in the context of growing demand.

Transcript

Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.